10.11.2021 Valneva Announces European Commission Approval of Advance Purchase Agreement for up to 60 Million Doses of Inactivated COVID-19 Vaccine VLA2001more
09.11.2021 Lithoz confirms global market leadership position in ceramic 3D printing according to new 3dpbm Research reportmore
09.11.2021 Nabriva Therapeutics Reports Third Quarter 2021 Financial Results and Provides a Corporate Updatemore
05.11.2021 Bahnbrechende neue Methode, um Potenzial von Cellulose-Nanofibrillen zur Herstellung von Supermaterialien voll auszuschöpfenmore
05.11.2021 Glioblastom und Autismus: Möglicher Mechanismus für die Fehlentwicklung von Nervenzellen gefundenmore
04.11.2021 Jens Thiel zum Professor für Rheumatologie berufen Entstehung entzündlicher Gelenkserkrankung als Forschungsschwerpunktmore
03.11.2021 Solv4U: Marinomed launches new business area enabling the development of innovative formulations in technology partnershipsmore
02.11.2021 Nabriva Therapeutics to Report Third Quarter 2021 Financial Results and Recent Corporate Highlights on November 9, 2021more
02.11.2021 Valneva Announces Launch of Proposed Global Offering of American Depository Shares and Ordinary Sharesmore
02.11.2021 Valneva Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Global Offering to Approximately $102.0 Millionmore